These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 10468183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A, Uğur-Bilgin A, Colak D, Tuncer M, Gölbaşi I, Hazar V, Kiliçarsłan B, Undar L, Demirbaş A.
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [Abstract] [Full Text] [Related]

  • 3. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 4. Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience.
    Micallef IN, Chhanabhai M, Gascoyne RD, Shepherd JD, Fung HC, Nantel SH, Toze CL, Klingemann HG, Sutherland HJ, Hogge DE, Nevill TJ, Le A, Barnett MJ.
    Bone Marrow Transplant; 1998 Nov 10; 22(10):981-7. PubMed ID: 9849695
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 10; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B, Kowalczyk JR, Chybicka A, Wachowiak J, Drabko K, Zaucha-Prazmo A, Choma M, Gorczyńska E, Toporski J, Turkiewicz D, Kałwak K, Pieczonka A, Boruczkowski D.
    Przegl Lek; 2004 Jun 10; 61 Suppl 2():53-6. PubMed ID: 15686047
    [Abstract] [Full Text] [Related]

  • 10. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
    Gong JZ, Bayerl MG, Sandhaus LM, Sebastian S, Rehder CW, Routbort M, Lagoo AS, Szabolcs P, Chiu J, Comito M, Buckley PJ.
    Am J Surg Pathol; 2006 Mar 10; 30(3):328-36. PubMed ID: 16538052
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: report of five pediatric cases.
    Lai YC, Ni YH, Jou ST, Ho MC, Wu JF, Chen HL, Hu RH, Jeng YM, Chang MH, Lee PH.
    Pediatr Transplant; 2006 May 10; 10(3):390-4. PubMed ID: 16677368
    [Abstract] [Full Text] [Related]

  • 13. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 May 10; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
    Montanari F, O'Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, Crook MT, Tsao L, Sevilla DW, Bhagat G, Alobeid B.
    Hum Pathol; 2010 Aug 10; 41(8):1150-8. PubMed ID: 20381113
    [Abstract] [Full Text] [Related]

  • 16. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S, Debray D, Delarue A, Deschênes G.
    Pediatr Nephrol; 2002 Aug 10; 17(8):668-72. PubMed ID: 12185479
    [Abstract] [Full Text] [Related]

  • 17. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, Busuttil RW, Ament ME.
    Transplantation; 2000 Jul 15; 70(1):94-9. PubMed ID: 10919581
    [Abstract] [Full Text] [Related]

  • 18. Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).
    Zimmermann T, Hoppe-Lotichius M, Tripkovic V, Barreiros AP, Wehler TC, Zimmermann A, Schattenberg JM, Heise M, Biesterfeld S, Galle PR, Otto G, Schuchmann M.
    Eur J Intern Med; 2010 Jun 15; 21(3):208-15. PubMed ID: 20493424
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
    Blaes AH, Peterson BA, Bartlett N, Dunn DL, Morrison VA.
    Cancer; 2005 Oct 15; 104(8):1661-7. PubMed ID: 16149091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.